Clinical trials
Pulmonary Embolism trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2006 | 2 |
| 2007 | 4 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 8 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 17 |
| Recruiting | 14 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Chao Yang Hospital | 6 |
| China-Japan Friendship Hospital | 5 |
| Peking Union Medical College Hospital | 5 |
| Bayer | 4 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 3 |
| Shengjing Hospital | 3 |
| Anthos Therapeutics, Inc. | 2 |
| Bristol-Myers Squibb | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Huashan Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Embolism | 62 |
| Venous Thrombosis | 17 |
| Venous Thromboembolism | 14 |
| Thrombosis | 8 |
| Thromboembolism | 5 |
| Lung Neoplasms | 4 |
| Clinical Deterioration | 3 |
| Disease | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Asthma | 2 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.